Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2016 (2016), Article ID 7685807, 7 pages
http://dx.doi.org/10.1155/2016/7685807
Review Article

Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges

Department of Pediatrics, Division of Pediatric Neurology, Hamad Medical Corporation, Doha, Qatar

Received 23 February 2016; Revised 31 March 2016; Accepted 10 April 2016

Academic Editor: Di Lazzaro Vincenzo

Copyright © 2016 Abdulhafeez M. Khair. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Davies, D. J. Connolly, and S. R. Mordekar, “Encephalopathy in children: an approach to assessment and management,” Archives of Disease in Childhood, vol. 97, no. 5, pp. 452–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Venkatesan, A. R. Tunkel, K. C. Bloch et al., “Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium,” Clinical Infectious Diseases, vol. 57, no. 8, pp. 1114–1128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Armangue, F. Leypoldt, and J. Dalmau, “Autoimmune encephalitis as differential diagnosis of infectious encephalitis,” Current Opinion in Neurology, vol. 27, no. 3, pp. 361–368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bigi, M. Hladio, M. Twilt, J. Dalmau, and S. M. Benseler, “The growing spectrum of antibody-associated inflammatory brain diseases in children,” Neurology: Neuroimmunology & Neuroinflammation, vol. 2, no. 3, article e92, 2015. View at Publisher · View at Google Scholar
  5. A. Vincent, C. G. Bien, S. R. Irani, and P. Waters, “Autoantibodies associated with diseases of the CNS: new developments and future challenges,” The Lancet Neurology, vol. 10, no. 8, pp. 759–772, 2011. View at Publisher · View at Google Scholar
  6. J. Granerod, H. E. Ambrose, N. W. Davies et al., “Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study,” The Lancet Infectious Diseases, vol. 10, no. 12, pp. 835–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Gable, H. Sheriff, J. Dalmau, D. H. Tilley, and C. A. Glaser, “The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the california encephalitis project,” Clinical Infectious Diseases, vol. 54, no. 7, pp. 899–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Dalmau, F. Graus, M. K. Rosenblum, and J. B. Posner, “Anti-hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients,” Medicine, vol. 71, no. 2, pp. 59–72, 1992. View at Google Scholar · View at Scopus
  9. F. Graus, F. Keime-Guibert, R. Reñe et al., “Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients,” Brain, vol. 124, no. 6, pp. 1138–1148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. R. Irani, S. Alexander, P. Waters et al., “Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia,” Brain, vol. 133, no. 9, pp. 2734–2748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Haberlandt, T. Bast, A. Ebner et al., “Limbic encephalitis in children and adolescents,” Archives of Disease in Childhood, vol. 96, no. 2, pp. 186–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. R. Florance, R. L. Davis, C. Lam et al., “Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents,” Annals of Neurology, vol. 66, no. 1, pp. 11–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. Goldberg, M. Titulaer, P. M. de Blank, A. Sievert, and N. Ryan, “Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature,” Pediatric Neurology, vol. 50, no. 2, pp. 181–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Titulaer, L. McCracken, I. Gabilondo et al., “Clinical features, treatment, and outcome of 500 patients with anti-NMDA receptor encephalitis,” Neurology, vol. 78, Article ID PL01.001, 2012. View at Publisher · View at Google Scholar
  15. N. Luca, T. Daengsuwan, J. Dalmau et al., “Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children,” Arthritis & Rheumatism, vol. 63, no. 8, pp. 2516–2522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Hacohen, S. Wright, P. Waters et al., “Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 7, pp. 748–755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Dale, S. R. Irani, F. Brilot et al., “N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica,” Annals of Neurology, vol. 66, no. 5, pp. 704–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ishiura, S. Matsuda, M. Higashihara et al., “Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab,” Neurology, vol. 71, no. 23, pp. 1921–1923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. C. Wong-Kisiel, T. Ji, D. L. Renaud et al., “Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis,” Neurology, vol. 74, no. 19, pp. 1550–1551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. B. Darnell and J. B. Posner, “A new cause of limbic encephalopathy,” Brain, vol. 128, no. 8, pp. 1745–1746, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Houtrow, M. Bhandal, N. R. Pratini, L. Davidson, and J. A. Neufeld, “The Rehabilitation of children with anti-N-methyl-D-aspartate-receptor encephalitis: a case series,” American Journal of Physical Medicine and Rehabilitation, vol. 91, no. 5, pp. 435–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Alexopoulos, M. L. Kosmidis, J. Dalmau, and M. C. Dalakas, “Paraneo-plastic anti-NMDAR encephalitis: Long term follow-up reveals persistent serum antibodies,” Journal of Neurology, vol. 258, no. 8, pp. 1568–1570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Rosenfeld and J. Dalmau, “Anti–NMDA-receptor encephalitis and other synaptic autoimmune disorders,” Current Treatment Options in Neurology, vol. 13, no. 3, pp. 324–332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M. R. Rosenfeld, and R. Balice-Gordon, “Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis,” The Lancet Neurology, vol. 10, no. 1, pp. 63–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Titulaer, L. McCracken, I. Gabilondo et al., “Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study,” The Lancet Neurology, vol. 12, no. 2, pp. 157–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. M. Szczepiorkowski, J. L. Winters, N. Bandarenko et al., “Guidelines on the use of therapeutic apheresis in clinical practice:evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis,” Journal of Clinical Apheresis, vol. 25, no. 3, pp. 83–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. DeSena, D. K. Noland, K. Matevosyan et al., “Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: a retrospective review,” Journal of Clinical Apheresis, vol. 30, no. 4, pp. 212–216, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kumar, “Manual (small) volume plasmapheresis: an effective and safe therapeutic procedure in acute neurological illness,” Annals of Indian Academy of Neurology, vol. 7, pp. 439–440, 2004. View at Google Scholar
  29. J. H. Smith, R. Dhamija, B. D. Moseley et al., “N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis,” Archives of Neurology, vol. 68, no. 8, pp. 1069–1072, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. P. Pham, J. A. Daniel-Johnson, B. A. Stotler, H. Stephens, and J. Schwartz, “Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis,” Journal of Clinical Apheresis, vol. 26, no. 6, pp. 320–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Ishiura, S. Matsuda, M. Higashihara et al., “Response of anti-nmda receptor encephalitis without tumor to immunotherapy including rituximab,” Neurology, vol. 71, no. 23, pp. 1921–1923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Agrawal, A. Vincent, L. Jacobson, D. Milford, R. Gupta, and E. Wassmer, “Successful treatment of antiN-methyl-d-aspartate receptor limbic encephalitis in a 22-monthold child with plasmapheresis and pharmacological immunomodulation,” Archives of Disease in Childhood, vol. 95, article 312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Schimmel, C. G. Bien, A. Vincent, W. Schenk, and J. Penzien, “Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia,” Archives of Disease in Childhood, vol. 94, no. 4, pp. 314–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. K. Mirza, J. Pogoriler, K. Paral et al., “Adjunct therapeutic plasma exchange for anti-N-methyl-D-aspartate receptor antibody encephalitis: a case report and review of literature,” Journal of Clinical Apheresis, vol. 26, no. 6, pp. 362–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. M. Simabukuro, R. G. S. Watanabe, L. F. Pinto, C. Guariglia, D. C. D. M. E. Gonçalves, and R. Anghinah, “A successful case of anti-NMDAR encephalitis without tumor treated with a prolonged regimen of plasmapheresis,” Dementia e Neuropsychologia, vol. 8, no. 1, pp. 87–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. D. S. Khurana, J. J. Melvin, S. V. Kothare et al., “Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis,” Pediatrics, vol. 116, no. 2, pp. 431–436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. R. R. Nair, M. Rafeequ, and A. S. Girija, “Plasmapheresis in childhood acute disseminated encephalomyelitis,” Indian Pediatrics, vol. 42, no. 5, pp. 479–482, 2005. View at Google Scholar · View at Scopus
  38. B. G. Weinshenker, P. C. O'Brien, T. M. Petterson et al., “A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease,” Annals of Neurology, vol. 46, no. 6, pp. 878–886, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Balestri, S. Grosso, A. Acquaviva, and M. Bernini, “Plasmapheresis in a child affected by acute disseminated encephalomyelitis,” Brain and Development, vol. 22, no. 2, pp. 123–126, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Miyazawa, A. Hikima, Y. Takano, H. Arakawa, T. Tomomasa, and A. Morikawa, “Plasmapheresis in fulminant acute disseminated encephalomyelitis,” Brain and Development, vol. 23, no. 6, pp. 424–426, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. B. M. Greenberg, K. P. Thomas, C. Krishnan, A. I. Kaplin, P. A. Calabresi, and D. A. Kerr, “Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide,” Neurology, vol. 68, no. 19, pp. 1614–1617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Dembinski, M. Gieron-Korthals, C. R. Martinez, and L. Rodriguez, “Neuromyelitis optica in child: diagnostic and therapeutic challenges,” Case Reports in Pediatrics, vol. 2013, Article ID 124929, 4 pages, 2013. View at Publisher · View at Google Scholar
  43. J. Mühlhausen, B. Kitze, P. Huppke, G. A. Müller, and M. J. Koziolek, “Apheresis in treatment of acute inflammatory demyelinating disorders,” Atherosclerosis Supplements, vol. 18, pp. 251–256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Yun, Z. Weihua, R. Xiaotun et al., “Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders,” Zhonghua Er Ke Za Zhi, vol. 53, no. 4, pp. 268–273, 2015. View at Google Scholar
  45. H. J. Yu, J. Lee, D. W. Seo, and M. Lee, “Clinical manifestations and treatment response in pediatric Hashimoto encephalopathy,” Journal of Child Neurology, vol. 29, no. 7, pp. 938–942, 2014. View at Google Scholar
  46. L. Nieuwenhuis, P. Santens, P. Vanwalleghem, and P. Boon, “Subacute Hashimoto's encephalopathy, treated with plasmapheresis,” Acta Neurologica Belgica, vol. 104, no. 2, pp. 80–83, 2004. View at Google Scholar · View at Scopus
  47. Ö. Bektas, A. Ylmaz, T. Kendirli, Z. Sklar, and G. Deda, “Hashimoto encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis,” Pediatric Neurology, vol. 46, no. 2, pp. 132–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Bartolucci, S. Bréchignac, P. Cohen, V. Le Guern, and L. Guillevin, “Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients,” Lupus, vol. 16, no. 10, pp. 817–822, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. C. M. Neuwelt, “The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus,” Therapeutic Apheresis and Dialysis, vol. 7, no. 2, pp. 173–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. S. E. Swedo, J. Seidlitz, M. Kovacevic et al., “Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings,” Journal of Child and Adolescent Psychopharmacology, vol. 25, no. 1, pp. 26–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Walls, M. Cubangbang, H. Wang et al., “Pediatric autoimmune neuropsychiatric disorders associated with streptococcus immunology: a pilot study,” Otolaryngology—Head and Neck Surgery, vol. 153, no. 1, pp. 130–136, 2015. View at Google Scholar
  52. S. J. Perlmutter, S. F. Leitman, M. A. Garvey et al., “Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood,” The Lancet, vol. 354, no. 9185, pp. 1153–1158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Besiroglu, M. Y. Agargun, O. Ozbebit, M. Sozen, I. Dilek, and M. Gulec, “Theraputic response to plasmapheresis in four cases with obsessive-compulsive disorders triggered by streptococcal infections,” Turk Psikiyatri Dergisi, vol. 18, no. 3, pp. 270–276, 2007. View at Google Scholar
  54. M. E. Latimer, N. L'Etoile, J. Seidlitz, and S. E. Swedo, “Therapeutic plasma apheresis as a treatment for 35 severely Ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with Streptococcal infections,” Journal of Child and Adolescent Psychopharmacology, vol. 25, no. 1, pp. 70–75, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. F. J. Kirkham, P. Haywood, P. Kashyape et al., “Movement disorder emergencies in childhood,” European Journal of Paediatric Neurology, vol. 15, no. 5, pp. 390–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Miranda, R. H. Walker, D. Saez, and V. Renner, “Severe Sydenham’s chorea (Chorea paralytica) successfully treated with plasmapheresis,” Journal of Clinical Movement Disorders, vol. 2, article 1, 2015. View at Publisher · View at Google Scholar
  57. I. Cortese, V. Chaudhry, Y. T. So, F. Cantor, D. R. Cornblath, and A. Rae-Grant, “Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology,” Neurology, vol. 76, no. 3, pp. 294–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. W. Rogers, P. I. Andrews, L. C. Gahring et al., “Autoantibodies to glutamate receptor GluR3 in Rasmussen's enceohalitis,” Science, vol. 265, no. 5172, pp. 648–651, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. C. G. Bien, T. Granata, C. Antozzi et al., “Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement,” Brain, vol. 128, no. 3, pp. 454–471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. E. P. Vining, “Struggling with Rasmussen's syndrome,” Epilepsy Currents, vol. 6, no. 1, pp. 20–21, 2006. View at Publisher · View at Google Scholar
  61. E. D. Tate, T. J. Allison, M. R. Pranzatelli, and S. J. Verhulst, “Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome,” Journal of Pediatric Oncology Nursing, vol. 22, no. 1, pp. 8–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Blaes, V. Fühlhuber, M. Korfei et al., “Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome,” Annals of Neurology, vol. 58, no. 2, pp. 313–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J. R. Scariff, B. Iftikhar, A. Tatugade, J. Choi, and S. Lippmann, “Opsoclonus myoclonus,” Innovations in Clinical Neuroscience, vol. 8, no. 12, pp. 29–31, 2011. View at Google Scholar · View at Scopus
  64. V. W. Y. Yiu, T. Kovithavongs, L. F. McGonigle, and P. Ferreira, “Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome,” Pediatric Neurology, vol. 24, no. 1, pp. 72–74, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. S. R. Sheela and P. J. Mani, “Opsoclonus myoclonus syndrome: response to plasmapheresis,” Indian Pediatrics, vol. 41, no. 5, pp. 499–502, 2004. View at Google Scholar · View at Scopus
  66. M. B. Armstrong, P. L. Robertson, and V. P. Castle, “Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis,” Pediatric Neurology, vol. 33, no. 5, pp. 365–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. H. Mokrzycki and A. A. Kaplan, “Therapeutic plasma exchange: complications and management,” American Journal of Kidney Diseases, vol. 23, no. 6, pp. 817–827, 1994. View at Publisher · View at Google Scholar · View at Scopus